173 related articles for article (PubMed ID: 26339132)
1. Elevated Serum Levels of Soluble TNF Receptors and Adhesion Molecules Are Associated with Diabetic Retinopathy in Patients with Type-1 Diabetes.
Sharma S; Purohit S; Sharma A; Hopkins D; Steed L; Bode B; Anderson SW; Caldwell R; She JX
Mediators Inflamm; 2015; 2015():279393. PubMed ID: 26339132
[TBL] [Abstract][Full Text] [Related]
2. Proteins of TNF-α and IL6 Pathways Are Elevated in Serum of Type-1 Diabetes Patients with Microalbuminuria.
Purohit S; Sharma A; Zhi W; Bai S; Hopkins D; Steed L; Bode B; Anderson SW; Reed JC; Steed RD; She JX
Front Immunol; 2018; 9():154. PubMed ID: 29445381
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of IL-6, sIL-6R, and sgp130 in the aqueous humor and serum of patients with diabetic retinopathy.
Chen H; Zhang X; Liao N; Wen F
Mol Vis; 2016; 22():1005-14. PubMed ID: 27563232
[TBL] [Abstract][Full Text] [Related]
4. Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy.
Sasongko MB; Wong TY; Jenkins AJ; Nguyen TT; Shaw JE; Wang JJ
Diabet Med; 2015 May; 32(5):686-91. PubMed ID: 25407692
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of interleukin 6 soluble receptor and its natural antagonist, sgp130, and the risk of myocardial infarction.
Moreno Velásquez I; Golabkesh Z; Källberg H; Leander K; de Faire U; Gigante B
Atherosclerosis; 2015 Jun; 240(2):477-81. PubMed ID: 25910182
[TBL] [Abstract][Full Text] [Related]
6. Serum vascular adhesion protein-1 correlates with vascular endothelial growth factor in patients with type II diabetes.
Yoshikawa N; Noda K; Shinoda H; Uchida A; Ozawa Y; Tsubota K; Mashima Y; Ishida S
J Diabetes Complications; 2013; 27(2):162-6. PubMed ID: 23062326
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
Gustavsson C; Agardh E; Bengtsson B; Agardh CD
J Diabetes Complications; 2008; 22(5):309-16. PubMed ID: 18413212
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of exhaled sICAM1, sVCAM1, and sE-selectin in patients with non-small cell lung cancer.
Zhou F; Chen J; Tao G; Zhu M; Xie W; Cao X
Respir Med; 2014 Nov; 108(11):1670-6. PubMed ID: 25179787
[TBL] [Abstract][Full Text] [Related]
9. Antinuclear antibodies are associated with tumor necrosis factor receptor I gene polymorphism in patients with rheumatoid arthritis.
Glossop JR; Dawes PT; Mattey DL
Clin Exp Rheumatol; 2011; 29(4):609-15. PubMed ID: 21813053
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial.
Muni RH; Kohly RP; Lee EQ; Manson JE; Semba RD; Schaumberg DA
JAMA Ophthalmol; 2013 Apr; 131(4):514-21. PubMed ID: 23392399
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory markers in a 2-year follow-up of coronary artery disease.
Mizia-Stec K; Gasior Z; Zahorska-Markiewicz B; Holecki M; Kumor P
Heart Vessels; 2006 Sep; 21(5):302-8. PubMed ID: 17151818
[TBL] [Abstract][Full Text] [Related]
12. Platelet expression of tumour necrosis factor-alpha (TNF-alpha), TNF receptors and intercellular adhesion molecule-1 (ICAM-1) in patients with proliferative diabetic retinopathy.
Limb GA; Webster L; Soomro H; Janikoun S; Shilling J
Clin Exp Immunol; 1999 Nov; 118(2):213-8. PubMed ID: 10540181
[TBL] [Abstract][Full Text] [Related]
13. Correlation of various serum biomarkers with the severity of diabetic retinopathy.
Nalini M; Raghavulu BV; Annapurna A; Avinash P; Chandi V; Swathi N; Wasim
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S451-S454. PubMed ID: 28420575
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
[TBL] [Abstract][Full Text] [Related]
15. High serum TNF-alpha level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells.
Makino N; Maeda T; Sugano M; Satoh S; Watanabe R; Abe N
J Diabetes Complications; 2005; 19(6):347-55. PubMed ID: 16260352
[TBL] [Abstract][Full Text] [Related]
16. [Serum levels of solubule tumor necrosis factor (TNF) receptors in patients with pulmonary tuberculosis].
Kawaguchi H; Ina Y; Ito S; Sato S; Sugiura Y; Tomita H; Ogisu N; Takada K; Yamamoto M; Morishita M; Yoshikawa K
Kekkaku; 1996 Mar; 71(3):259-65. PubMed ID: 8901228
[TBL] [Abstract][Full Text] [Related]
17. Soluble receptors and cytokine antagonists in human milk.
Buescher ES; Malinowska I
Pediatr Res; 1996 Dec; 40(6):839-44. PubMed ID: 8947960
[TBL] [Abstract][Full Text] [Related]
18. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
Adamiec J; Oficjalska-Młyńczak J
Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
[TBL] [Abstract][Full Text] [Related]
19. Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children.
Sikora JP; Kuzański W; Andrzejewska E
Med Sci Monit; 2009 Jan; 15(1):CR26-31. PubMed ID: 19114968
[TBL] [Abstract][Full Text] [Related]
20. Production of soluble tumor necrosis factor receptors and tumor necrosis factor-alpha by alveolar macrophages in sarcoidosis and extrinsic allergic alveolitis.
Dai H; Guzman J; Chen B; Costabel U
Chest; 2005 Jan; 127(1):251-6. PubMed ID: 15653992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
